Updated: Oct 7, 2008
Partial anomalous pulmonary venous connection (PAPVC) is a rare congenital cardiac defect. As the name suggests, in PAPVC, the blood flow from a few of the pulmonary veins return to the right atrium instead of the left atrium. Usually, a single pulmonary vein is anomalous. Rarely, all the veins from one lung are anomalous. Thus, some of the pulmonary venous flow enters the systemic venous circulation.
Embryologically, PAPVC is similar to total anomalous pulmonary venous connection (TAPVC); however, TAPVC differs in that all or most pulmonary venous vessels connect to the right side of the heart in TAPVC. Knowledge of the variation patterns of normal pulmonary venous drainage is necessary in order to diagnose PAPVC.
PAPVC from the right lung is twice as common as PAPVC from the left lung. The most common form of PAPVC is one in which a right upper pulmonary vein connects to the right atrium or the superior vena cava. This form is almost always associated with a sinus venosus type of atrial septal defect (ASD).
The right pulmonary veins can also drain into the inferior vena cava. The left pulmonary veins can drain into the innominate vein, the coronary sinus, and, rarely, the cavae, right atrium, or left subclavian vein.
Anatomically, PAPVC can involve a wide variety of connections, and can be subdivided into the following categories:
Numerous factors determine the ratio of pulmonary blood flow (Qp) to systemic flow (Qs). The shunt magnitude, expressed as the Qp:Qs ratio, and other factors determine development of symptoms and complications.
The most important factor is the number of pulmonary veins that drain into the systemic circulation. The more veins that anomalously drain, the more blood returns to the right side of the heart. Some authors have suggested that this defect becomes clinically significant when 50% or more of the pulmonary veins anomalously return.
In addition, the source of the returning blood plays a role in determining the clinical effect of the defect. In an individual who is upright, blood flow to the lungs is primarily directed to the lower and middle lobes. Therefore, more blood returns to the systemic venous circulation in individuals in whom the anomalous connection drains into either the right middle and lower lobes or the left lower lobe of the lung.
An associated cardiac defect, such as an ASD, may add to the left-to-right shunting.
In scimitar syndrome, the flow from the PAPVC causes a left-to-right shunt. Again, the number of anomalous veins involved determines the symptoms and signs. The aberrant artery may cause additional left-to-right shunt.
Over many years, excessive pulmonary venous return to the right side of the heart causes right atrial and ventricular dilation. This has numerous consequences, including risk of arrhythmia development, right-sided heart failure, and development of pulmonary hypertension.
A native PAPVC usually does not have any associated obstruction to venous drainage. However, obstruction may occur postoperatively due to baffle obstruction.
Most data regarding prevalence of this condition have been garnered from autopsy series that estimate an incidence of 0.4-0.7%. However, autopsy series may overestimate the clinical significance of this condition because many of these cases were asymptomatic; thus, the true incidence of patients who present antemortem with this condition is lower. Clinical diagnosis of isolated PAPVC is quite rare. PAPVC occurs in approximately 10% of patients with a proven ASD.
Few data are available regarding mortality due to this lesion because mortality credited to the defect occurs only in adults and the diagnosis has historically been made at autopsy. Major morbidity, including arrhythmias, right-sided cardiac failure, and, rarely, pulmonary vascular disease, also primarily occurs in adults.
No data regarding racial predilection are available.
The incidence is higher in the female population.
PAPVC is a congenital defect. Clinical evidence of this congenital defect may not be apparent until the patient reaches middle age.
Children with partial anomalous pulmonary venous connection (PAPVC) usually remain asymptomatic and are referred based on an incidentally noted cardiac murmur. Symptoms may occur in older patients and may be secondary to right-sided volume overload or pulmonary vascular obstructive disease.
Determining the natural history of this condition was difficult before the era of direct cardiac imaging (ie, echocardiography, cardiac catheterization) because the diagnosis was made only postmortem.
The development of complications from PAPVC clearly depends on how many pulmonary veins abnormally return to the right heart. A single anomalous vein is not usually hemodynamically significant and, hence, does not produce any symptoms.
About 10% of patients with an atrial septal defect (ASD) also have PAPVC and may have symptoms of right-sided overload.
The severity of symptoms in scimitar syndrome depends on several factors, including degree of pulmonary hypertension and the severity and frequency of chest infections. Scimitar syndrome can present in neonates, children, and adults and is related to the degree of pulmonary hypoplasia.
Physical examination findings are usually more revealing than the history, but positive findings depend on the volume of abnormal pulmonary venous return to the right heart. If only a single vein is anomalous, the physical examination findings may be normal. In a patient with a larger volume of abnormal veins, physical examination findings are similar to those of an uncomplicated ASD. These findings include the following:
No causes of this condition are known. No evidence has implicated common teratogens (eg, drugs, infections) in the genesis of PAPVC. No evidence for a genetic predisposition has been reported.
| Atrial Septal Defect, Coronary Sinus | Total Anomalous Pulmonary Venous
Connection |
| Atrial Septal Defect, Ostium Primum | Ventricular Septal Defect, Muscular |
| Atrial Septal Defect, Ostium Secundum | Ventricular Septal Defect,
Perimembranous |
| Atrial Septal Defect, Patent Foramen
Ovale | Ventricular Septal Defect, Supracristal |
| Atrial Septal Defect, Sinus Venosus |
Imaging studies in partial anomalous pulmonary venous connection (PAPVC) include the following:
Medical therapy of partial anomalous pulmonary venous connection (PAPVC) is not indicated for asymptomatic patients. Heart failure in adults can be managed with diuretics, cardiac glycosides, afterload reduction, and beta blockade. Arrhythmias should be appropriately treated.
Definitive treatment for PAPVC is surgical repair. Indications for surgical repair are controversial.
One school of thought claims that all children should undergo repair because of the exceptionally low morbidity and mortality following this surgical procedure. Others suggest that appropriate criteria include a significant left-to-right shunt (Qp:Qs of about 2:1 or more) or such as an entire lung that anomalously drains, before recommending surgery.
Operative technique depends on the site of the anomalous vein or veins. The usual approach is a midline sternotomy and cardiopulmonary bypass. Surgical treatment of associated lesions may be necessary.
For the PAPVC to the superior vena cava (SVC), the repair techniques may include internal patch technique, with or without SVC enlargement, or the caval division technique with atriocaval anastomosis (Warden technique). Children with internal patch technique must be observed for obstruction of the SVC with SVC syndrome, sick sinus syndrome, obstruction of the pulmonary veins, and supraventricular tachyarrhythmias.
No specific diet is recommended or prohibited.
No limitation on activity is necessary in the pediatric patient.
Medication is not currently a component of care in this condition. See Treatment.
Lilje C, Weiss F, Weil J. Detection of partial anomalous pulmonary venous connection by magnetic resonance imaging. Pediatr Cardiol. Jul-Aug 2005;26(4):490-1. [Medline].
Julsrud PR, Ehman RL. The "broken ring" sign in magnetic resonance imaging of partial anomalous pulmonary venous connection to the superior vena cava. Mayo Clin Proc. Dec 1985;60(12):874-9. [Medline].
Gustafson RA, Warden HE, Murray GF, et al. Partial anomalous pulmonary venous connection to the right side of the heart. J Thorac Cardiovasc Surg. Nov 1989;98(5 Pt 2):861-8. [Medline].
Xue JR, Luo Y, Cheng P, Cao RW. [Diagnosis and treatment of partial anomalous pulmonary venous connection]. Zhonghua Yi Xue Za Zhi. Apr 15 2008;88(15):1066-8. [Medline].
Coulson JD, Bullaboy CA. Concentric placement of stents to relieve an obstructed anomalous pulmonary venous connection. Cathet Cardiovasc Diagn. Oct 1997;42(2):201-4. [Medline].
Danilowicz D, Kronzon I. Use of contrast echocardiography in the diagnosis of partial anomalous pulmonary venous connection. Am J Cardiol. Feb 1979;43(2):248-52. [Medline].
Elami A, Rein AJ, Preminger TJ, et al. Tetralogy of Fallot, absent pulmonary valve, partial anomalous pulmonary venous return and coarctation of the aorta. Int J Cardiol. Dec 1995;52(3):203-6. [Medline].
Forbess LW, O'Laughlin MP, Harrison JK. Partially anomalous pulmonary venous connection: demonstration of dual drainage allowing nonsurgical correction. Cathet Cardiovasc Diagn. Jul 1998;44(3):330-5. [Medline].
Hazirolan T, Ozkan E, Haliloglu M, et al. Complex venous anomalies: magnetic resonance imaging findings in a 5-year-old boy. Surg Radiol Anat. Oct 2006;28(5):534-8. [Medline].
Jemielity M, Perek B, Paluszkiewicz L, et al. Results of repair of partial anomalous pulmonary venous connection and sinus venosus atrial septal defect in adults. J Heart Valve Dis. Jul 1998;7(4):410-4. [Medline].
Nakahira A, Yagihara T, Kagisaki K, et al. Partial anomalous pulmonary venous connection to the superior vena cava. Ann Thorac Surg. Sep 2006;82(3):978-82. [Medline].
Powell AJ, Chung T, Landzberg MJ, Geva T. Accuracy of MRI evaluation of pulmonary blood supply in patients with complex pulmonary stenosis or atresia. Int J Card Imaging. Jun 2000;16(3):169-74. [Medline].
Respondek-Liberska M, Janiak K, Moll J, et al. Prenatal diagnosis of partial anomalous pulmonary venous connection by detection of dilatation of superior vena cava in hypoplastic left heart. A case report. Fetal Diagn Ther. Sep-Oct 2002;17(5):298-301. [Medline].
Ritter S, Tani LY, Shaddy RE, et al. An unusual variant of total anomalous pulmonary venous connection with varices and multiple drainage sites. Pediatr Cardiol. May-Jun 2000;21(3):289-91. [Medline].
Shahriari A, Rodefeld MD, Turrentine MW, Brown JW. Caval division technique for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection. Ann Thorac Surg. Jan 2006;81(1):224-9; discussion 229-30. [Medline].
Valsangiacomo ER, Hornberger LK, Barrea C, et al. Partial and total anomalous pulmonary venous connection in the fetus: two-dimensional and Doppler echocardiographic findings. Ultrasound Obstet Gynecol. Sep 2003;22(3):257-63. [Medline].
Vanderheyden M, Goethals M, Van Hoe L. Partial anomalous pulmonary venous connection or scimitar syndrome. Heart. Jul 2003;89(7):761. [Medline]. [Full Text].
partial anomalous pulmonary venous connection, intact atrial septum, PAPVC, isolated partial anomalous pulmonary venous connection, total anomalous pulmonary venous connection, TAPVC, sinus venosus atrial septal defect, ASD, congential heart disease, heterotaxia, scimitar syndrome, secundum ASD, secundum atrial septal defect, polysplenia, Halasz syndrome, mirror-image lung syndrome, hypogenetic lung syndrome, epibronchial right pulmonary artery syndrome, vena cava bronchovascular syndrome, congenital pulmonary venolobar syndrome, cardiac murmur, hepatomegaly, jugular venous distension, ascites, peripheral edema
Monesha Gupta, MD, MBBS, FAAP, FACC, Assistant Professor, Division of Pediatric Pediatric Cardiology, University of Texas Medical School, Children's Memorial Hermann Hospital
Monesha Gupta, MD, MBBS, FAAP, FACC is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Society of Echocardiography, Medical Council of India, and Society of Pediatric Echocardiography
Disclosure: Nothing to disclose.
David J Vaughan, MBBCh, Consultant Pediatrician, Department of Pediatrics, Our Lady of Lourdes Hospital, Ireland
David J Vaughan, MBBCh is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.
Jerry Zimmerman, MD, PhD, Professor, Department of Pediatrics/Anesthesia, University of Washington School of Medicine; Director, Division of Pediatric Critical Care Medicine, Children's Hospital of Seattle
Jerry Zimmerman, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, Society for Pediatric Research, and Society of Critical Care Medicine
Disclosure: Nothing to disclose.
Ronald G Grifka, MD, Professor of Pediatrics, Michigan State University College of Human Medicine; Chief, Cardiology Division, DeVos Children's Hospital
Ronald G Grifka, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Medical Association, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.
Ira H Gessner, MD, Professor Emeritus, Pediatric Cardiology
Ira H Gessner, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.
Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from broker recommendation; Avanir Pharma Stock Investment from broker recommendation
Hugh D Allen, MD, Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine
Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, and Western Society for Pediatric Research
Disclosure: Nothing to disclose.
Gilbert Herzberg, MD, Assistant Professor, Department of Pediatrics, Section of Pediatric Cardiology, New York Medical College
Gilbert Herzberg, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.
Stuart Berger, MD, Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin
Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)